These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 28667476)

  • 21. 3D model for TM region of the AT-1 receptor in complex with angiotensin II independently validated by site-directed mutagenesis data.
    Nikiforovich GV; Marshall GR
    Biochem Biophys Res Commun; 2001 Sep; 286(5):1204-11. PubMed ID: 11527428
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Crystal structure of the human σ1 receptor.
    Schmidt HR; Zheng S; Gurpinar E; Koehl A; Manglik A; Kruse AC
    Nature; 2016 Apr; 532(7600):527-30. PubMed ID: 27042935
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oxo-bridged isomers of aza-trishomocubane sigma (sigma) receptor ligands: Synthesis, in vitro binding, and molecular modeling.
    Banister SD; Moussa IA; Jordan MJ; Coster MJ; Kassiou M
    Bioorg Med Chem Lett; 2010 Jan; 20(1):145-8. PubMed ID: 19954972
    [TBL] [Abstract][Full Text] [Related]  

  • 24. New Insights into the Opening of the Occluded Ligand-Binding Pocket of Sigma1 Receptor: Binding of a Novel Bivalent RC-33 Derivative.
    Rossino G; Orellana I; Caballero J; Schepmann D; Wünsch B; Rui M; Rossi D; González-Avendaño M; Collina S; Vergara-Jaque A
    J Chem Inf Model; 2020 Feb; 60(2):756-765. PubMed ID: 31809025
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Discovery of high-affinity ligands of sigma1 receptor, ERG2, and emopamil binding protein by pharmacophore modeling and virtual screening.
    Laggner C; Schieferer C; Fiechtner B; Poles G; Hoffmann RD; Glossmann H; Langer T; Moebius FF
    J Med Chem; 2005 Jul; 48(15):4754-64. PubMed ID: 16033255
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An update on the development of drugs for neuropsychiatric disorders: focusing on the sigma 1 receptor ligand.
    Hayashi T; Su TP
    Expert Opin Ther Targets; 2008 Jan; 12(1):45-58. PubMed ID: 18076369
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthesis, pharmacological evaluation, and σ1 receptor interaction analysis of hydroxyethyl substituted piperazines.
    Weber F; Brune S; Korpis K; Bednarski PJ; Laurini E; Dal Col V; Pricl S; Schepmann D; Wünsch B
    J Med Chem; 2014 Apr; 57(7):2884-94. PubMed ID: 24617836
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression pattern of the type 1 sigma receptor in the brain and identity of critical anionic amino acid residues in the ligand-binding domain of the receptor.
    Seth P; Ganapathy ME; Conway SJ; Bridges CD; Smith SB; Casellas P; Ganapathy V
    Biochim Biophys Acta; 2001 Jul; 1540(1):59-67. PubMed ID: 11476895
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rigidity versus Flexibility: Is This an Issue in σ1 Receptor Ligand Affinity and Activity?
    Weber F; Brune S; Börgel F; Lange C; Korpis K; Bednarski PJ; Laurini E; Fermeglia M; Pricl S; Schepmann D; Wünsch B
    J Med Chem; 2016 Jun; 59(11):5505-19. PubMed ID: 27156565
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multiple protective functions of sigma1 receptor.
    Skrzycki M; Czeczot H
    Curr Protein Pept Sci; 2014; 15(8):798-811. PubMed ID: 25466544
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Computational elucidation of the structural basis of ligand binding to the dopamine 3 receptor through docking and homology modeling.
    Hobrath JV; Wang S
    J Med Chem; 2006 Jul; 49(15):4470-6. PubMed ID: 16854052
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular determinants of ligand binding modes in the histamine H(4) receptor: linking ligand-based three-dimensional quantitative structure-activity relationship (3D-QSAR) models to in silico guided receptor mutagenesis studies.
    Istyastono EP; Nijmeijer S; Lim HD; van de Stolpe A; Roumen L; Kooistra AJ; Vischer HF; de Esch IJ; Leurs R; de Graaf C
    J Med Chem; 2011 Dec; 54(23):8136-47. PubMed ID: 22003888
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Investigation of the Entry Pathway and Molecular Nature of σ1 Receptor Ligands.
    Pascarella G; Antonelli L; Narzi D; Battista T; Fiorillo A; Colotti G; Guidoni L; Morea V; Ilari A
    Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37047338
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis and biological evaluation of a new series of hexahydro-2H-pyrano[3,2-c]quinolines as novel selective σ1 receptor ligands.
    Díaz JL; Christmann U; Fernández A; Luengo M; Bordas M; Enrech R; Carro M; Pascual R; Burgueño J; Merlos M; Benet-Buchholz J; Cerón-Bertran J; Ramírez J; Reinoso RF; Fernández de Henestrosa AR; Vela JM; Almansa C
    J Med Chem; 2013 May; 56(9):3656-65. PubMed ID: 23560650
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Structure prediction and molecular dynamics simulations of a G-protein coupled receptor: human CCR2 receptor.
    Singh R; Sobhia ME
    J Biomol Struct Dyn; 2013; 31(7):694-715. PubMed ID: 22909007
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of structural motifs critical for epstein-barr virus-induced molecule 2 function and homology modeling of the ligand docking site.
    Zhang L; Shih AY; Yang XV; Kuei C; Wu J; Deng X; Mani NS; Mirzadegan T; Sun S; Lovenberg TW; Liu C
    Mol Pharmacol; 2012 Dec; 82(6):1094-103. PubMed ID: 22930711
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis of spiro-2,6-dioxopiperazine and spiro-2,6-dioxopyrazine scaffolds using amino acids in a three-component reaction to generate potential Sigma-1 (σ
    Uprety R; Váradi A; Allaoa A; Redel-Traub GN; Palmer TC; Feinberg EN; Ferris AC; Pande VS; Pasternak GW; Majumdar S
    Eur J Med Chem; 2019 Feb; 164():241-251. PubMed ID: 30597325
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Discovery of 2-(3,4-dichlorophenoxy)-N-(2-morpholin-4-ylethyl)acetamide: A selective σ1 receptor ligand with antinociceptive effect.
    Navarrete-Vázquez G; Austrich-Olivares A; Godínez-Chaparro B; Hidalgo-Figueroa S; Estrada-Soto S; Hernández-Núñez E; Torres-Gómez H; Schepmann D; Wünsch B
    Biomed Pharmacother; 2016 Apr; 79():284-93. PubMed ID: 27044839
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A comprehensive ligand based mapping of the σ₂ receptor binding pocket.
    Rhoades DJ; Kinder DH; Mahfouz TM
    Med Chem; 2014; 10(1):98-121. PubMed ID: 23521001
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development of sigma-1 (σ1) receptor fluorescent ligands as versatile tools to study σ1 receptors.
    Abate C; Riganti C; Pati ML; Ghigo D; Berardi F; Mavlyutov T; Guo LW; Ruoho A
    Eur J Med Chem; 2016 Jan; 108():577-585. PubMed ID: 26717207
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.